What is FNC Medical?
FNC Medical operates as a specialized manufacturer and provider of high-efficacy hygiene and skin care solutions. The company's portfolio is anchored by its No-Risc hand sanitizers and the Ca-Rezz line of antibacterial products, which are specifically engineered to address the needs of patients with diabetes, incontinence, and chronic dry skin. By bridging the gap between consumer-grade hygiene and clinical-grade dermatological care, FNC Medical serves a dual market of individual end-users and institutional healthcare facilities. Beyond its proprietary product offerings, the company leverages its infrastructure to provide contract manufacturing services, positioning itself as a versatile player in the medical supply chain. This strategic diversification allows the firm to maintain robust revenue streams while upholding rigorous standards for antibacterial efficacy and skin health maintenance.
How much funding has FNC Medical raised?
FNC Medical has raised a total of $114K across 1 funding round:
Debt
$114K
Debt (2021): $114K with participation from PPP
Key Investors in FNC Medical
PPP
Public-Private Partnership
What's next for FNC Medical?
With the recent influx of capital, FNC Medical is well-positioned to accelerate its late-stage growth objectives. The strategic focus will likely shift toward optimizing supply chain resilience and expanding the reach of its contract manufacturing division. As the healthcare industry continues to prioritize advanced hygiene protocols, FNC Medical is poised to leverage its established product efficacy to capture additional market share. Future initiatives may include the scaling of production facilities to accommodate larger institutional contracts and the potential development of new dermatological formulations. By maintaining its commitment to community-focused health solutions, the company is set to reinforce its reputation as a critical partner in the broader medical and personal care ecosystem, ensuring long-term sustainability and operational excellence in an evolving regulatory landscape.
See full FNC Medical company page